Home » Topics » Regulatory » Patents

Patents
RSS

Vascular Strategies patents mTOR inhibitors

Jan. 5, 2017

Global Blood Therapeutics develops KLKB1 inhibitors

Jan. 5, 2017

Astellas Pharma discloses dopamine D1 receptor PAMs

Jan. 4, 2017

Adhaere Pharmaceuticals presents anticancer agents

Jan. 4, 2017

Almirall describes JAK inhibitors

Jan. 4, 2017

University of Florida discloses aminoacyl-tRNA synthetase inhibitors

Jan. 4, 2017

Bayer Pharma patents muscarinic acetylcholine M2 receptor PAMs

Jan. 4, 2017

Australian scientists present KAT6A inhibitors

Jan. 3, 2017

Bayer Pharma reports development of anticancer agents

Jan. 3, 2017

Lilly describes MetAP2 inhibitors

Jan. 3, 2017

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...